Ultrasensitive and highly selective detection of Alzheimer's disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle.
Alzheimer's disease (AD) is a progressive mental disorder disease, which affects 26.6 million people worldwide and estimated increments can be 100 millions by 2050. Since there is no cure at present, early diagnosis of AD is crucial for the current drug treatments. Driven by the need, here we demonstrate for the first time that monoclonal anti-tau antibody-coated gold nanoparticle based two-photon scattering assay can be used for the detection of Alzheimer's tau protein in the 1 pg/mL level which is about 2 orders of magnitude lower than cutoff values (195 pg/mL) for tau protein in CSF (cerebrospinal fluid). We have shown that when anti-tau antibody-coated gold nanoparticles were mixed with 20 ng/mL of tau protein, two-photon Rayleigh scattering intensity (TPRS) increases by about 16 times. The mechanism of TPRS intensity change has been discussed. Our data demonstrated that our TPRS assay is highly sensitive to tau protein and it can distinguish from BSA, which is one of the most abundant protein components in CSF. Our results demonstrate the potential for a broad application of this type of nanobionanotechnology in practical biomedical applications.
Neely
Adria
A
Department of Chemistry, Jackson State University, Jackson, Mississippi.
Perry
Candice
C
Varisli
Birsen
B
Singh
Anant K
AK
Arbneshi
Tahir
T
Senapati
Dulal
D
Kalluri
Jhansi Rani
JR
Ray
Paresh Chandra
PC
D000544:Alzheimer Disease / Q000175:diagnosis / Q000378:metabolism*; D000911:Antibodies, Monoclonal / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D003124:Colorimetry; D006046:Gold / Q000737:chemistry*; D016014:Linear Models; D053768:Metal Nanoparticles / Q000737:chemistry*; D017785:Photons; D012542:Scattering, Radiation; D016875:tau Proteins / Q000276:immunology / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D016875:tau Proteins; D006046:Gold
Chemistry. 2007;13(11):3160-8
17245786
J Am Chem Soc. 2009 May 13;131(18):6362-3
19368386
J Am Chem Soc. 2006 Feb 15;128(6):2115-20
16464114
Chemistry. 2009;15(2):342-51
19035615
ACS Nano. 2009 Jan 27;3(1):80-6
19206252
Neuroreport. 1997 Dec 22;8(18):3961-3
9462474
ACS Nano. 2008 Apr;2(4):677-86
19206598
Phys Rev Lett. 1991 Jun 10;66(23):2980-2983
10043668
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2273-6
15695586
Brain. 2006 Nov;129(Pt 11):3035-41
17012293
Nano Lett. 2008 Jun;8(6):1729-35
18489171
ACS Nano. 2008 Mar;2(3):449-56
19206569
ACS Nano. 2009 Jul 28;3(7):1906-12
19572619
ACS Nano. 2009 Jan 27;3(1):21-6
19206244
Nat Nanotechnol. 2009 Apr;4(4):215-6
19350028
Chemistry. 2008;14(13):3896-903
18348156
Chemistry. 2009;15(22):5436-40
19388044
Nat Biotechnol. 2004 Jan;22(1):47-52
14704706
Alzheimers Dement. 2007 Jul;3(3):186-91
19595937
Nature. 2006 May 25;441(7092):489-93
16724062
Angew Chem Int Ed Engl. 2008;47(51):9883-6
18988216
Angew Chem Int Ed Engl. 2009;48(22):3996-8
19408267
Nat Rev Neurosci. 2009 May;10(5):333-44
19339974
Chem Rev. 2008 Jan;108(1):109-39
18095717
ACS Nano. 2008 Apr;2(4):687-92
19206599
Small. 2009 Apr;5(7):839-45
19219836
Nat Mater. 2009 Jun;8(6):453-4
19458645
ACS Nano. 2007 Oct;1(3):208-14
19206651
Nat Rev Neurosci. 2008 Oct;9(10):768-78
18802446
Angew Chem Int Ed Engl. 2008;47(16):2978-81
18338413
Chemistry. 2007;13(27):7753-61
17610220
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2263-4
15703290
Small. 2008 Dec;4(12):2204-8
19003819
Talanta. 2008 Jan 15;74(4):1038-42
18371746
J Phys Chem B. 2006 Oct 26;110(42):20745-8
17048879
J Am Chem Soc. 2009 Feb 18;131(6):2072-3
19170493
Chemistry. 2008;14(12):3637-44
18318025
J Am Chem Soc. 2008 Jun 25;130(25):8038-43
18517205
Angew Chem Int Ed Engl. 2006 Feb 6;45(7):1151-4
16404762
J Am Chem Soc. 2005 Feb 23;127(7):2264-71
15713105